Central Region, Central, Singapore Majuven is the famous VC, which was founded in 2011. The company was established in Asia in Singapore. The main office of represented VC is situated in the Singapore.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Singapore. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CrownBio, Eureka Therapeutics, 17 Media. We can highlight the next thriving fund investment areas, such as E-Commerce, Agriculture. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.
The high activity for fund was in 2013. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2016. This Majuven works on 7 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Majuven, startups are often financed by Vertex Ventures Southeast Asia & India, Vertex Ventures, Qiming Venture Partners. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures Southeast Asia & India, Vertex Ventures, Convergence Ventures. In the next rounds fund is usually obtained by YJ Capital, PT Media Nusantara Citra Tbk. (MNC Media Group), K2 Global.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Alfaro & Partners | - |
| Cascade Ventures | - |
| CB Capital LLC | Oregon, Portland, United States |
| Deutsche Bahn | Frankfurt, Germany, Hessen |
| Hongli Innovation Investment | China, Guangdong, Shenzhen |
| International Cannabis Corp | British Columbia, Canada, Vancouver |
| Kashen Chenghe Jishi Chuang Tou | - |
| Lotus Life Foundation | - |
| Network Capital Holding AG | Switzerland, Zug, Zug |
| Odyssey Research | Bismarck, North Dakota, United States |
| Pacific General Ventures | Atherton, California, United States |
| Rutech Ventures | - |
| SBV Capital | Lees Summit, Missouri, United States |
| Shanghai Jiushi | China, Shanghai |
| Spring St. Group | New York, New York, United States |
| The Parkmead Group | Aberdeen, Scotland, United Kingdom |
| The Vinik Family Foundation | - |
| Xizang Zhengji Jijin Guanli | - |
| Zhongchanng Data | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Turnkey Lender | $6M | 20 Apr 2021 | Austin, Texas, United States | ||
TechStorm | 31 May 2019 | Central | |||
Nuohui Health | $66M | 24 May 2019 | Dongcheng District, Beijing, China | ||
Turnkey Lender | $4M | 06 Mar 2019 | Austin, Texas, United States | ||
Fundnel | 06 Oct 2017 | Singapore, Singapore | |||
Paktor | $10M | 11 Jul 2016 | Singapore, Central, Singapore | ||
Paktor | $7M | 14 Jul 2015 | Singapore, Central, Singapore | ||
Paraplou | $1M | 06 Feb 2015 | Indonesia, Jakarta | ||
Eureka Therapeutics | $21M | 23 Sep 2014 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Turnkey Lender | $6M | 20 Apr 2021 | Austin, Texas, United States | ||
TechStorm | 31 May 2019 | Central | |||
Nuohui Health | $66M | 24 May 2019 | Dongcheng District, Beijing, China | ||
Turnkey Lender | $4M | 06 Mar 2019 | Austin, Texas, United States | ||
Fundnel | 06 Oct 2017 | Singapore, Singapore | |||
Paktor | $10M | 11 Jul 2016 | Singapore, Central, Singapore | ||
Paktor | $7M | 14 Jul 2015 | Singapore, Central, Singapore | ||
Paraplou | $1M | 06 Feb 2015 | Indonesia, Jakarta | ||
Eureka Therapeutics | $21M | 23 Sep 2014 | California, United States |
